#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial calcification Pleural mesothelioma Endocrine ophthalmopathy Dedifferentiated liposarcoma Adenovirus infection Glomerulonephritis Metastases to peritoneum Arteriosclerosis Hereditary hypophosphataemic rickets Propionic acidaemia Hyperchylomicronaemia Follicular lymphoma stage II Neuroblastoma recurrent B-cell small lymphocytic lymphoma refractory Alport's syndrome More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex Angiosarcoma metastatic – Trials in Disease Angiosarcoma non-metastatic – Basic Information Primary hyperoxaluria – Life with Disease CADASIL – Diagnostics Prader-Willi syndrome – Treatment Pemphigoid Piriformis syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Osteosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FRUQUINTINIB Evencaleucel Nadroparin Calcium Arrhenatherum Elatius Allopurinol GSKVX000000039711 Ciprofloxacin Hydrochloride Dosulepin Hydrochloride Tazemetostat Nefopam Hydrochloride Gozetotide PF-07868489 Fluconazole Kk8123 RO7795081 Cusatuzumab ATIRMOCICLIB Epcoritamab Alteplase Av-Ec2023 More therapies…

    Learn about Your Condition

    Small intestine leiomyosarcoma Mantle cell lymphoma stage III Small intestine adenocarcinoma Netherton's syndrome Breast cancer metastatic Optic ischaemic neuropathy Anorexia nervosa Progressive supranuclear palsy Anaemia of pregnancy Solitary fibrous tumour Proteus syndrome Primary hyperthyroidism Cutaneous sarcoidosis Urea cycle disorder Cold urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rectal cancer

  • Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    Italy

  • Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study on Induction Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, and Oxaliplatin for Patients with High-Risk Locally Advanced Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colon cancer
    • Breast cancer
    • Rectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Ireland

  • Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!